Channel 9 Health Reporter Gabriella Rogers explores the potential therapeutic benefits of Cynata’s MSC product in this serious disease and reviews the SCULpTOR trial with Professor David Hunter
Addressing The Challenges Of MSCs Will Reveal A Bright Future For This Regenerative Medicine Modality.
Celebrating Fantastic Women in Regenerative Medicine: An Interview With Cynata’s Dr Suzanne Lipe, Vice President of Partner Engagement.
Read More at RegMedNet
Jessica Allen of the Market Herald speaks with Dr Ross Macdonald about Cynata's recent successful capital raise and the Company’s plans to deploy the additional funds.
Watch the video on themarketherald.com.au
(Timecode 8:29)
Stuart Roberts, respected analyst and industry commentator at Pitt Street Research speaks with Dr Ross Macdonald about Cynata's market position, research and clinical trials.
Interview with Dr Ross MacDonald, CEO Cynata Therapeutics (ASX:CYP) 20 November 2020 from Pitt Street Research on Vimeo.